CC
BMY icon

Cadinha & Co’s Bristol-Myers Squibb BMY Stock Holding History

Cadinha & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,333
Closed -$203K – 102
2025
Q1 		$203K Buy
+3,333
New +$194K 0.04% 98
2023
Q1 		– Sell
-2,834
Closed -$204K – 93
2022
Q4 		$204K Sell
2,834
-883
-24% -$66.6K 0.05% 98
2022
Q3 		$264K Sell
3,717
-192,963
-98% -$14M 0.09% 79
2022
Q2 		$15.1M Buy
+196,680
New +$15M 3.38% 11
2018
Q4 		– Sell
-19,353
Closed -$1.2M – 108
2018
Q3 		$1.2M Sell
19,353
-193,623
-91% -$11.5M 0.19% 62
2018
Q2 		$11.8M Sell
212,976
-947
-0.4% -$51.1K 2.16% 22
2018
Q1 		$13.5M Buy
213,923
+314
+0.1% +$20.2K 2.73% 17
2017
Q4 		$13.1M Buy
213,609
+36,309
+20% +$2.27M 1.81% 25
2017
Q3 		$11.3M Buy
177,300
+161,540
+1,025% +$9.43M 1.93% 23
2017
Q2 		$878K Buy
15,760
+11,395
+261% +$620K 0.15% 64
2017
Q1 		$237K Sell
4,365
-4,718
-52% -$259K 0.05% 113
2016
Q4 		$531K Buy
9,083
+3,975
+78% +$217K 0.09% 73
2016
Q3 		$275K Hold
5,108
– – 0.06% 102
2016
Q2 		$376K Buy
5,108
+100
+2% +$7.07K 0.08% 86
2016
Q1 		$320K Buy
5,008
+325
+7% +$20.5K 0.08% 87
2015
Q4 		$322K Buy
4,683
+37
+0.8% +$2.44K 0.08% 81
2015
Q3 		$275K Hold
4,646
– – 0.07% 86
2015
Q2 		$309K Hold
4,646
– – 0.06% 87
2015
Q1 		$300K Hold
4,646
– – 0.06% 91
2014
Q4 		$274K Hold
4,646
– – 0.05% 97
2014
Q3 		$238K Hold
4,646
– – 0.04% 97
2014
Q2 		$225K Hold
4,646
– – 0.04% 100
2014
Q1 		$241K Sell
4,646
-4,500
-49% -$239K 0.04% 93
2013
Q4 		$486K Hold
9,146
– – 0.09% 71
2013
Q3 		$423K Hold
9,146
– – 0.08% 68
2013
Q2 		$409K Buy
+9,146
New +$397K 0.09% 61

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cadinha & Co's BMY Position: Q2 2025 in Review

Cadinha & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,333 shares — an estimated $203K sold.

Cadinha & Co first reported a position in BMY in Q2 2013 and held it in 26 quarters. The position peaked at $15.1M in Q2 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Cadinha & Co reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Cadinha & Co sold 3,333 Bristol-Myers Squibb shares in Q2 2025, an estimated $203K.
  • Cadinha & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 26 quarters.
  • Cadinha & Co's Bristol-Myers Squibb position peaked at $15.1M in Q2 2022.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Cadinha & Co's 13F filing for Q2 2025, filed 31 Jul 2025.